New article: Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma https://t.co/1TCrgrYnZW #pancreaticcancer #oncology https://t.co/EMggE8zdrK
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
RT @Aiims1742: Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. I…
Near pathological complete response (pCR) in a patient with #PancreaticCancer, receiving neoadjuvant SBRT & pembrolizumab. It all comes down to the underlying tumor biology. A similar trial by @mkatzmd @OsamaRahma2 et al had a few striking responses to
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
RT @DNA_gyrase: Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thrivin…
Last year I saw a patient with #PancreaticCancer and I told her she only had months to live. This is her story of thriving in the face of adversity and a hopeful bright future for pancreatic cancer: @DocPatM @vreelant @lexyadams16 @PanCAN @letswinpc h